Contact Information

A262 ASTeCC Building
University of Kentucky
Lexington, KY 40506-0286

phone: 859-218-6515
fax: 859-257-2489

Contact by email

Positions

• Professor
  Pharmacy Practice and Science Department
• Professor
  Martin School of Public Policy and Administration
• Professor
  UK College of Public Health
• Professor
  UK College of Health Sciences
• Faculty Associate
  Center on Drug and Alcohol Abuse
• Program Associate
  UK Program for Bioethics and Patients' Rights

Joseph Fink - B.S.Pharm., J.D., F.A.Ph.A.

Joseph L. Fink III is Professor of Pharmacy at the University of Kentucky College of Pharmacy, where he focuses on pharmaceutical public policy and pharmacy law, and Professor of Public Health in the UK College of Public Health. In addition, he also is a Professor in the Martin School of Public Policy and Administration, a unit he served as Acting Director during 1998. Finally, he is a Professor of Clinical Leadership and Management in the UK College of Health Sciences. He also holds appointments as a Faculty Associate with the UK Appalachian Center, Faculty Associate with the UK Center on Drug and Alcohol Research, and as a Program Associate with the UK Program for Bioethics and Patients' Rights.

He has been Vice President for Research and Economic Development, Vice President for Corporate Relations and Economic Outreach as well as Special Assistant to the President for Academic Affairs at UK . He was Associate Vice Chancellor for Academic Affairs at UK from 1988 to 1996. Additionally, he served as Executive Director of UK Coldstream Research Campus, the University's 735 acre research park in Lexington from 2002 to 2004. He was Assistant Dean of the UK College of Pharmacy from 1981 to 1988 and Acting Director of the UK Appalachian Center during 2004-2005.

He received his professional education in pharmacy at the Philadelphia College of Pharmacy and Science and holds the degree Doctor of Law from Georgetown University Law Center, where he was Chairman of the Moot Court Board. He is licensed to practice pharmacy in Kentucky and Pennsylvania and has been admitted to the practice of law in Kentucky and Pennsylvania as well as before the United States Supreme Court. He is also trained in both general mediation and health care mediation, completing the latter at the Harvard School of Public Health.

He served on the faculty of the Philadelphia College of Pharmacy and Science from 1973 to 1981, rising from Assistant Professor to the rank of Professor. During 1985-86 he served an American Council on Education Fellowship in Academic Administration.

He holds membership in a number of professional organizations in both pharmacy and law, including the American Pharmacists Association and the American Bar Association. He is a Fellow of APhA and a former Vice Speaker of the House of Delegates of the Association. He chaired the committee for the latest revision of the APhA Code of Ethics for Pharmacists and currently serves the Association as Parliamentarian for the House of Delegates. He was founder and first president of the American Society for Pharmacy Law and, while a pharmacy student, was National President of the Student American Pharmaceutical Association. The Kentucky Pharmacists Association recognized him as "Pharmacist-of-the-Year" for 1988 and in 2002 conferred on him the Distinguished Service Award for significant contributions to the profession over an extended period of time. He has twice received the "Great Teacher Award" from the University of Kentucky National Alumni Association . He has also twice been recognized nationally for his leadership and scholarly contributions to his specialty area of the law and in 2004 the American Society for Pharmacy Law established the Joseph L. Fink III Founders Leadership Award in his honor. In 2003 he received the Annual Alumni Achievement Award from his Philadelphia alma mater and in 2005 he was recognized with the Phi Lambda Sigma-Procter & Gamble National Leadership Award in pharmacy. During 2007 he was recognized by UK with both the President's Award for Diversity and the William E. Lyons Award for Outstanding Service to the University, Community and the Commonwealth. During 2009 he received the Robert G. Zumwinkle Student Rights Award at UK for "protecting, enforcing and futhering student rights" through his service as Chair of the University Appeals Board for ten years.

He serves as UK's Faculty Athletics Representative to the Southeastern Conference and the National Collegiate Athletics Association and as a member of the UK Athletics Association Board.

His scholarly works include over 340 publications in the fields of law pertaining to pharmacy, pharmacists and pharmaceuticals, food and drug law, and health care law. For over twenty years he served as an Editor of Pharmacy Law Digest, the most widely used pharmacy law text and reference in the United States . His teaching includes a pharmacy course focusing on the law applicable to pharmacists, pharmacies, and pharmaceuticals as well as a health law course taught to graduate students in health administration. His extramural grant support exceeds one million dollars as Principal Investigator and nearly four mllion in all grant-related roles.

Selected Honors

• American Society for Pharmacy Law; Best Legal Research Paper (2007) entitled, “OBRA ’90 at Sweet Sixteen – A Retrospective Review”
• University of Kentucky; 2007 President’s Diversity Award
• Inducted into Omicron Delta Kappa National Leadership Society; UK Chapter
• UK Office of Research/ODYSSEY Magazine; 25 Movers and Shapers of UK during the Past Twenty-five Years
• 2007 William E. Lyons Award for Outstanding Service to the University, Community, and State
• Elected to membership in the Kentucky Institute of Medicine, 2008

Selected Publications/Presentations

• Fink III JL. Career connections: Reflections on life as a professor teaching health law to non-law studetns. Health Lawyers News. 2007(April);11:14-16.
• Fink III JL. Pharmacy law brief: Non-competition agreements in pharmacy practice. Kentucky Pharm. 2007(May-June);2:16.
• Fink III JL. Another federal court rejects a drug importation plan. Pharm Times. 2007(May);73:84.
• Yusuf J-E, Fink III JL. Technology-based economic development: Connecting the research university and community leaders. Applied Res in Econ Development. 2007;4:95-105.
• Fink III JL. Administrative degree options outside pharmacy for pharmacists interested in administrative careers in the health care filed. Hosp Pharm. 2007(July);42:626-630.
• McKinley SS, Fink III JL. "Speed Limits": States' approaches to regulating access to methamphetamine chemical precursors with statutes and regulations limiting pseudoephedring availability. 82 North Dakota Law Rev. 1217-1247 (2007).
• Fink III JL. Drug firms' blocking imports does not violate antitrust. Pharm Times. 2007(July);73:108.
• Fink III JL. Court declines again to review pact delaying entry of generics. Pharm Times. 2007(Oct);73:92.
• Fink III JL. Ethics and a code of ethics in pharmacy practice. Special Additional Introduction in White BD. Drugs, Ethics and Quality of Life: Cases and Materials on Ethical, Legal, and Public Policy Dilemmas in Medicine and Pharmacy Practics. Binghamton, NY: The Haworth Press;2007,p.7-12.
• Fink III JL. May a database be "searched" for evidence of criminal activity? Pharm Times. 2008(Jan);74:54.
• Fink III JL. Do patients have a Constitutional right of access to investigational drugs? Pharm Times. 2008(Feb);74:74.
• Vivian JC, Fink III JL. OBRA '90 at Sweet Sixteen - A Retrospective Review. U.S. Pharm. 2008(Mar);33:59-61, 65.
• Hamby LM, Fink III JL. "Methamphetamine in Kentucky: Geographical inferences from arrest data, 1995-2004. "in University of Kentucky Special Commission on the Study of Methamphetamine and Other Emerging Drugs in Kentucky, Report on Methamphetamine and Other Drug Use in Kentucky. Lexington, KY:The University of Ketnucky Office of the President(2008),pp.21-27.
• Fink III JL. May administrative regulations be used to support a claim of negligence? Pharm Times. 2008(Apr);74:68.
• Fink III JL. Pharmacy and public policy: Evolution of the legal and regulatory framework for generic interchange. J Pharm Tech. 2008(May-June);24:132-36.
• Fink III JL. Legal implications of prescribing over the Internet. Pharm Times. 2008(June);75:50.
• Fink III JL. Accommodating pharmacists who refuse certain patients. Pharm Times. 2008(Oct);74:90.
• Viviam JC, Fink III JL, Whisman TR. Use of legally marketed drugs for lethal injection. US Pharm. 2008(Nov.);33:40-42.
• Fink III JL. Potential legal exposure with community service as a board member of a non-profit organization. Kentucky Pharm. 2008(Nov.);3:14-15.
• Romanelli F, Whisman TR, Fink III JL. Issues surrounding lethal injection as a means for capital punishment. Pharmacotherapy. 2008(Dec);28:1429-36.
• Mattingly II TJ, Yusuf JE, Fink III JL. Turning that great idea into a thriving business. Pharm Times. 2009(Feb);75:50-51.

Teaching

Website Links

• ASTeCC
• Martin School of Public Policy
• Center for Drug and Alcohol Research
• Program for Bioethics and Patients' Rights
• UK Appalachian Center